Alessandro Cozzi-Lepri

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (9)

emanuele nicastri

ITALY

View details

Giuseppe LAPADULA

Associate Professor

University of Milano-Bicocca

ITALY

View details

Rasmus L. Marvig

Associate Professor

Technical University of Denmark

DENMARK

View details

Antonella d'Arminio Monforte

Full Professor

Università degli Studi di Torino

ITALY

View details

Camilla Tincati

University of Milan

ITALY

View details

Claudio Maria MASTROIANNI

Full Professor in Infectious Diseases

Università degli Studi di Roma La Sapienza

ITALY

View details

maria santoro

Assistant professor

University of Rome Tor Vergata

ITALY

View details

loredana sarmati

Associate Professor of Infectious Diseases

Università degli Studi di Roma La Sapienza

ITALY

View details

Christof Stingone

Istituto Dermatologico San Gallicano

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alessandro Cozzi-Lepri

Research Interests

Explore related searches

Contact this professor

Articles (10)

Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort

Comparative Analysis of Early COVID‐19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target Trials

Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster Vaccine

The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 Study

Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy

Probability of Starting Two-Drug Regimen (2DR) vs. Three-Drug Regimen (3DR) in ART-Naïve and ART-Experienced Person with HIV (PWH) Across the First Wave of COVID-19 Pandemic

Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route

Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis – results from the ICONA cohort in Italy, 2009-2022

Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study

Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (START) study

Collaborators (9)

emanuele nicastri

Giuseppe LAPADULA

Rasmus L. Marvig

Antonella d'Arminio Monforte

Camilla Tincati

Claudio Maria MASTROIANNI

maria santoro

loredana sarmati

Christof Stingone

Make your next move.